Ramdas Rajamani Subramanium
About Ramdas Rajamani Subramanium
Data last updated:
Ramdas Rajamani Subramanium was a Director at Bulwark Impex Private Limited (2017–2019), Director at Niyama Pharmaceuticals Private Limited (2019–2022) and Director at Bulwark Armour Private Limited (2017–2019), and held 1 more directorship. The companies operate in Travel and Hospitality, Pharma and Equipment & Machinery.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bulwark Impex Private Limited U01113MH2017PTC302226 | Director | 27 Nov 2017 | 2017 | ₹53.44 Cr (FY 2024) | Active |
| Niyama Pharmaceuticals Private Limited U24304MH2018PTC317902 | Director | 21 Jan 2019 | 2018 | Active | |
| Bulwark Armour Private Limited U29100MH2017PTC295691 | Director | 02 Jun 2017 | 2017 | ₹1.59 Cr (FY 2025) | Active |
| Em Tec Management Solution Llp AAF-5325 | Designated Partner | 04 Aug 2016 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramdas Rajamani Subramanium
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramdas Rajamani Subramanium
Ramdas Rajamani Subramanium was first appointed on 04 Aug 2016 as Designated Partner at Em Tec Management Solution Llp. The most recent appointment on record is 21 Jan 2019 at Niyama Pharmaceuticals Private Limited.
Ramdas Rajamani Subramanium held 4 earlier board appointments: Bulwark Impex Private Limited (Director, 27 Nov 2017 to 07 Jun 2019); Niyama Pharmaceuticals Private Limited (Director, 21 Jan 2019 to 09 May 2022); Bulwark Armour Private Limited (Director, 02 Jun 2017 to 07 Jun 2019); Em Tec Management Solution Llp (Designated Partner, 04 Aug 2016 to 01 Dec 2019).